MIER1

MIER1 is a transcriptional corepressor that assembles chromatin-modifying complexes and silences target genes through multiple, partly independent mechanisms (PMID:12482978, PMID:15117948). Its conserved ELM2 domain recruits the histone deacetylase HDAC1, conferring trichostatin A-sensitive repression and defining the first known function of this domain (PMID:12482978). In parallel, MIER1 inhibits acetylation by directly binding the histone acetyltransferase CBP through its N-terminal half and abolishing CBP HAT activity without displacing histones (PMID:18721470), and it interacts with the transcription factor Sp1 via a region containing its SANT domain to displace Sp1 from GC-box promoter elements in an HDAC-independent manner (PMID:15117948). Beyond enzyme recruitment, MIER1 binds H2A:H2B dimers and intact nucleosomes carrying the repressive H3K27me2/3 mark as part of a MIER1:HDAC1:BAHD1:C1QBP assembly, consistent with a histone-chaperone role that expands repressed chromatin downstream of PRC2 (PMID:37099381). MIER1 activity is gated by subcellular partitioning: alternative splicing generates isoforms that differ in nuclear versus cytoplasmic localization, with inclusion of exon 3A encoding a CRM1-dependent nuclear export signal that drives cytoplasmic accumulation of the alpha isoform (PMID:12242014, PMID:22384264). Through an LXXLL motif the MI-ER1alpha isoform also binds estrogen receptor alpha and restrains estrogen-stimulated anchorage-independent growth (PMID:18665173). Physiologically, MIER1 couples metabolic state to proliferation: acute lipid accumulation triggers EIF2S1 phosphorylation that attenuates Mier1 translation, relieving repression of cell-cycle genes and promoting liver regeneration (PMID:36934083).

1. 2002 Medium

   Established that MIER1 produces functionally distinct isoforms partitioned between compartments, framing localization as a regulatory layer over its activity.

   Evidence transfection of tagged alpha/beta isoforms with fractionation and microscopy

   PMID:12242014

   Open questions at the time

   • did not define the molecular signal driving export of the alpha isoform
   • no functional consequence of compartment switch tested
2. 2003 High

   Answered how MIER1 represses transcription by showing the ELM2 domain recruits HDAC1, assigning the first function to ELM2.

   Evidence GAL4-fusion repression assay, deletion mapping, and HDAC1 co-immunoprecipitation

   PMID:12482978

   Open questions at the time

   • endogenous target genes not identified
   • did not address HDAC-independent repression routes
3. 2004 High

   Showed MIER1 also represses through a deacetylase-independent route by binding Sp1 via its SANT region and evicting Sp1 from GC-box promoters.

   Evidence Co-IP, ChIP at the hmi-er1 promoter, reporter assays, and Sp1 DNA-binding interference

   PMID:15117948

   Open questions at the time

   • generality beyond the autoregulatory hmi-er1 promoter unknown
   • structural basis of SANT–Sp1 contact not defined
4. 2008 Medium

   Extended the repression model to acetylation by demonstrating MIER1 binds and inactivates CBP HAT activity through its N-terminal half.

   Evidence GST pull-down, in vivo HAT activity assay, and histone peptide binding in HEK293

   PMID:18721470

   Open questions at the time

   • mechanism of HAT inhibition (allosteric vs. occlusion) unresolved
   • single lab, not independently replicated
5. 2008 Medium

   Connected MIER1 to nuclear-receptor signaling by identifying ligand-modulated ERalpha binding via an LXXLL motif and a growth-suppressive consequence.

   Evidence Co-IP in HEK293/MCF-7 and anchorage-independent growth assay in T47D

   PMID:18665173

   Open questions at the time

   • transcriptional targets co-regulated with ERalpha not mapped
   • in vivo relevance to breast tissue untested
6. 2012 High

   Resolved the mechanism of isoform localization by showing exon 3A encodes a CRM1-dependent NES that exports MIER1alpha.

   Evidence NES mutagenesis, leptomycin B inhibition, and fluorescence microscopy

   PMID:22384264

   Open questions at the time

   • signals controlling exon 3A splicing choice unknown
   • functional output of cytoplasmic MIER1alpha not defined
7. 2023 Medium

   Reframed MIER1 as a histone chaperone acting downstream of PRC2 by showing it binds H2A:H2B and H3K27me2/3 nucleosomes within a BAHD1/C1QBP/HDAC1 assembly.

   Evidence co-purification/mass spectrometry, biochemical reconstitution, and nucleosome binding assays

   PMID:37099381

   Open questions at the time

   • chaperone activity not demonstrated in a deposition/eviction assay
   • stoichiometry and architecture of the larger complex unresolved
8. 2023 High

   Placed MIER1 in a physiological circuit linking metabolism to proliferation, where translational repression of MIER1 derepresses cell-cycle genes during liver regeneration.

   Evidence in vivo CRISPR screen, EIF2S1 phosphorylation/translation assays, chromatin remodeling analysis, and knockout mouse models

   PMID:36934083

   Open questions at the time

   • specific chromatin loci remodeled by MIER1 in hepatocytes not mapped
   • generality to other regenerating tissues unknown
9. 2025 Medium

   Defined a B-cell repressor complex (MIER1–ARID5B–C16ORF87–HDAC1/2) tethered to active promoters, linking MIER1 to control of proliferation and signaling genes.

   Evidence proteomics and CUT&RUN genomic mapping (preprint)

   Open questions at the time

   • preprint, not peer-reviewed
   • direct vs. indirect target genes not separated
   • recruitment mechanism to active elements unclear
10. 2025 Low

    Began to define the structural architecture of MIER1 corepressor assembly, with the HDAC2 C-terminal IDR bridging the MIER1 ELM2 domain and MHAP1.

    Evidence crosslinking mass spectrometry plus integrative computational docking (preprint)

    Open questions at the time

    • primarily computational with no mutagenesis validation
    • preprint, not peer-reviewed
    • no experimental high-resolution structure

• How MIER1's distinct repression modes (HDAC recruitment, CBP inhibition, Sp1 displacement, histone chaperoning) are coordinated on a given target, and what dictates target gene selection across tissues, remains unresolved.
• no unified model integrating the repression mechanisms
• genome-wide direct target catalog incomplete
• context-dependent partner selection unexplained